Pharma industry

Lupin recalls over 18,000 bottles of antibiotic drug in the US

Lupin recalls over 18,000 bottles of antibiotic drug in the US

1 min read . 16 Jun 2019

A file photo of Dilip Shanghvi. The chosen set of doctors was sponsored for medical conferences year after year. Sun devised ways to help their patient flows, expand their market, and, in turn, its profits (Bloomberg)

How ethical dilemmas tailed Sun Pharma’s rise

9 min read . 30 May 2019

Pharma sales growth for the full fiscal year is a respectable 9.6%. (Sarvesh Kumar Sharma/Mint)

Pharma sales growth back to normal in March after strong boost in winter

1 min read . 18 Apr 2019

Among Indian pharma firms, Dr Reddy's is ahead in China with most drug approvals. (Vipul Sharma/Mint)

Dr Reddy's China focus will require deft manoeuvring

1 min read . 28 Mar 2019

The new Drugs and Clinical Trials Rules, 2019, has done away with formality of conducting local tests so that the drugs can be introduced in India sooner. (iStock)

No clinical trials in India for new drugs approved in select developed markets

2 min read . 26 Mar 2019

SoftBank, which recently sold its stake in online retailer Flipkart to Walmart, is keen to enter the online pharma retail space, which it has identified as a key growth area. (Pradeep Gaur/Mint)

PharmEasy in early funding talks with SoftBank at double its valuation

2 min read . 25 Mar 2019

Lupin's revenue growth has improved in FY19, helped by reduced pricing pressure in the US generic drugs business. (Vipul Sharma/Mint)

US FDA woes dull Lupin's growth revival allure

1 min read . 15 Mar 2019

A large part of the recent growth in pharma sales was contributed by price hikes. (Sarvesh Kumar Sharma/Mint)

Price hikes continue to drive pharma sales in India

1 min read . 06 Mar 2019

The move to cap margin of 42 cancer drugs could affect companies like Sun Pharma, Glenmark, Zydus Cadila and Biocon. (Bloomberg)

India puts 42 non-scheduled cancer drugs under price control

3 min read . 28 Feb 2019

For Indian pharma companies, chances of a rebound in US revenues in FY20 are quite high. (iStock)

Unexciting Q3 results of pharma companies give cues about the US market

2 min read . 21 Feb 2019

According to public health experts, the medical device industry is ridden with loopholes; regulation thus is extremely important. (Bloomberg)

India to regulate medical implants to ensure their safety

2 min read . 08 Feb 2019

Opinion | The illness plaguing India’s pharmaceutical sector

Opinion | The illness plaguing India’s pharmaceutical sector

4 min read . 24 Jan 2019

Domestic drugmakers and civil rights activists called the govt’s move a ‘pro-pharma’ step, with ‘no element of public interest’. Photo: Bloomberg

Govt move to exempt key foreign-made drugs from price control draws flak

2 min read . 05 Jan 2019

The revoking of the price cap on innovative medicines, including orphan drugs, gives Indian patients access to foreign medicines, says the government. Photo: iStocke

Govt removes price cap on innovative drugs for first 5 years

1 min read . 04 Jan 2019

Sun Pharma shares on Wednesday ended 2.23% down at Rs414 apiece on the BSE. Photo: Mint

Sun Pharma arm gets relief from US court in patent infringement case

1 min read . 26 Dec 2018

The API manufacturing units in China have been shut down due to environmental concerns. Photo: Pradeep Gaur/Mint (Pradeep Gaur/Mint)

Pharma lobby for hiking cost of drugs under govt price control

2 min read . 12 Nov 2018

Cipla: A perfect storm in one quarter

2 min read . 07 Nov 2018

Branded generics dominate drug market: CCI

2 min read . 25 Oct 2018

Make it large—a significant trend in the Indian pharmaceutical industry

3 min read . 25 Sep 2018

Biologics are important market disrupters because they are transforming how we treat diseases, including certain types of cancer, rheumatoid arthritis, and multiple sclerosis. Photo: Hindustan Times

Opinion | The need for growth in Indian biosimilars

4 min read . 03 Sep 2018